KINGCHEM LIAONING LIFE SCI

Kingchem Liaoning Life Science Q3 2026: Flat Shares, Capacity Expansion, and Profit Outlook

Kingchem Liaoning Life Science’s latest Q3 report shows modest revenue growth but a sharp profit dip, while new production projects signal future resilience.

KINGCHEM LIAONING LIFE SCI
China
AI generated

Jake Connors

23/10/2026, 13:38

3 minutes to read

Kingchem Liaoning Life Science: Biotech Upside Amid Flat Trading & Strong Pipeline

Investors eye Kingchem Liaoning Life Science: flat trading, 18% below trend, yet a biotech pipeline and strategic partners hint at upside potential.

KINGCHEM LIAONING LIFE SCI
China
AI generated

Samantha Roth

23/10/2026, 06:08

3 minutes to read